Earnings Per Share, Basic in USD/shares of Tvardi Therapeutics, Inc. from Q1 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2013 to Q3 2025.
  • Tvardi Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.59 USD/shares, a 72.4% increase year-over-year.
  • Tvardi Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 6 USD/shares.
  • Tvardi Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -15.5 USD/shares, a 40.9% increase from 2023.
  • Tvardi Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -26.3 USD/shares, a 37.3% decline from 2022.
  • Tvardi Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -19.1 USD/shares, a 999% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6.00 -$1 +$1.55 +72.4% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $4.00 $0.51 +$3.22 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $1.00 -$3 +$17.00 +84.1% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 -$15 $9.56 +$34.20 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$49 -$2 -$2 -312% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$48 -$3 -$2 -367% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$46 -$20 -$20 -4031% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 -$26 -$25 -$7 -36.4% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$19 -$1 $0 -20.9% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$19 -$1 -$1 -625% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$19 $0 +$0.03 +5.77% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$19 -$18 -$18 -2727% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2025
Q3 2022 -$1 $0 $0 -2050% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$1 $0 +$0.53 +86.9% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$1 -$1 $0 -10.6% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$1 -$1 -$2 -140% 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2024
Q3 2021 $0 $0 +$0.33 +94.3% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $0 -$1 $0 -13% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 $0 $0 +$0.15 +24.2% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $0 $1.60 01 Oct 2020 31 Dec 2020 10-K 25 Feb 2021
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-K 25 Feb 2021
Q2 2020 -$1 01 Apr 2020 30 Jun 2020 10-K 25 Feb 2021
Q1 2020 -$1 01 Jan 2020 31 Mar 2020 10-K 25 Feb 2021
Q2 2014 $0 -$1 -147% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2014
Q4 2013 -$1 $0 01 Oct 2013 31 Dec 2013 10-K 27 Mar 2015
Q3 2013 -$1 01 Jul 2013 30 Sep 2013 10-K 27 Mar 2015
Q2 2013 $0.34 01 Apr 2013 30 Jun 2013 10-K 27 Mar 2015
Q1 2013 $0 01 Jan 2013 31 Mar 2013 10-K 27 Mar 2015

Tvardi Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$16 +$10.70 +40.9% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$26 -$7 -37.3% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 -$19 -$17 -999% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025
2021 -$2 -$2 -1067% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024
2020 $0.18 +$2.67 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023
2019 -$2 $0 -20.9% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 -$2 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.